New bioanalytical microemulsion Electrokinetic chromatography method for the simultaneous determination of Trifluridine with its metabolites and Tipiracil in rat plasma: Application to pharmacokinetic studies

被引:5
作者
Hefnawy, Mohamed [1 ,2 ]
Alzamil, Adeeba [1 ]
Abuelizz, Hatem [1 ]
AlShehri, Mona [1 ]
机构
[1] King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, POB 2457, Riyadh 11451, Saudi Arabia
[2] Mansoura Univ, Fac Pharm, Dept Analyt Chem, Mansoura 35516, Egypt
关键词
Microemulsion electrokinetic; chromatography (MEEKC); Colorectal cancer; Trifluridine/Tipiracil; Metabolites; Bioanalysis; Pharmacokinetics; METASTATIC COLORECTAL-CANCER; THYMIDINE PHOSPHORYLASE; PLUS BEVACIZUMAB; OPEN-LABEL; TAS-102;
D O I
10.1016/j.jsps.2019.09.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A Microemulsion Electrokinetic Chromatography method coupled with diode array detector (MEEKCDAD) was developed for the first time and found to be efficient, sensitive, and selective for the simultaneous analysis of Trifluridine (FTD), and its metabolites 5-(trifluoromethyl) uracil (FTY) and 5-carboxy-2'-deoxyuridine (5CDU), and Tipiracil (TIP) in rat plasma. Sample pre-treatment involved a simple protein precipitation from plasma using acetonitrile. The separation was achieved using a fused silica capillary (65 cm total length, 55 cm effective length and 50 mu m i.d.) and a microemulsion solution consisted of 1.66% sodium dodecyl sulfate (SDS), 0.91% heptane, 6.61% 1-butanol, and 90.72% borate buffer (20 mM, pH 9.5). Electrophoretic separation was carried out at 20 degrees C and 20 kV. The samples were injected for 40 s at 20 mbar and detected simultaneously at 205 nm. The electrophoretic parameters indicated that the developed MEEKC-DAD method permitted complete resolution of the analytes within 13 min. The developed method was fully validated according to the FDA guidelines for bioanalytical method validation. The method was linear in the range 200-4000 ng/ml for FTD, FTY, 5CDU, and 100-1000 ng/ml for TIP. The intra/inter-day accuracy and precisions were <= 4% for all drugs. Extraction recovery and stability were also assessed and were within acceptable range. After being validated, the method was applied for the determination of the studied drugs in plasma samples collected from rats injected intraperitoneally with a combination of FTD and TIP. The results obtained were used to study the pharmacokinetics of FTD with its metabolite and TIP in rat plasma. (C) 2019 The Author(s). Published by Elsevier B.V. on behalf of King Saud University.
引用
收藏
页码:1075 / 1084
页数:10
相关论文
共 37 条
[1]  
Altria K. D., 2006, INTRO QUANTITATIVE A, VVI
[2]   The effect of operating variables in microemulsion electrokinetic capillary chromatography [J].
Altria, KD ;
Clark, BJ ;
Mahuzier, PE .
CHROMATOGRAPHIA, 2000, 52 (11-12) :758-768
[3]  
[Anonymous], 2012, INT J PHARM TECH RES
[4]  
[Anonymous], 2018, EST CANC INC MORT PR
[5]  
Baker D. R., 1995, CAPILLARY ELECTROPHO
[6]  
CARE V., 2003, INDIAN J PHARM, V35, P257
[7]   A phase 1 study of the pharmacokinetics of nucleoside analog trifluridine and thymidine phosphorylase inhibitor tipiracil (components of TAS-102) vs trifluridine alone [J].
Cleary, James M. ;
Rosen, Lee S. ;
Yoshida, Kenichiro ;
Rasco, Drew ;
Shapiro, Geoffrey I. ;
Sun, Weijing .
INVESTIGATIONAL NEW DRUGS, 2017, 35 (02) :189-197
[8]   Phase I study of TAS-102 treatment in Japanese patients with advanced solid tumours [J].
Doi, T. ;
Ohtsu, A. ;
Yoshino, T. ;
Boku, N. ;
Onozawa, Y. ;
Fukutomi, A. ;
Hironaka, S. ;
Koizumi, W. ;
Sasaki, T. .
BRITISH JOURNAL OF CANCER, 2012, 107 (03) :429-434
[9]   Structure and activity of specific inhibitors of thymidine phosphorylase to potentiate the function of antitumor 2′-deoxyribonucleosides [J].
Fukushima, M ;
Suzuki, N ;
Emura, T ;
Yano, S ;
Kazuno, H ;
Tada, Y ;
Yamada, Y ;
Asao, T .
BIOCHEMICAL PHARMACOLOGY, 2000, 59 (10) :1227-1236
[10]  
Goday S., 2017, Int. J. Res. Appl, V5, P93